{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:19Z","timestamp":1792456819214,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.parkreldis.2023.105890","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:17:20Z","timestamp":1697001440000},"page":"105890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0083-3666","authenticated-orcid":false,"given":"Zhuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105890_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2023.105890_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parkreldis.2022.06.004","article-title":"Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: a systematic review and meta-analysis","volume":"101","author":"Wong","year":"2022","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2023.105890_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","article-title":"Peripheral lymphocyte subsets as a marker of Parkinson's disease in a Chinese population","volume":"33","author":"Cen","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.parkreldis.2023.105890_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.parkreldis.2021.02.008","article-title":"Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: an 8-year longitudinal study","volume":"85","author":"Ye","year":"2021","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2023.105890_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","article-title":"CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature","volume":"21","author":"Louveau","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105890_bib6","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1212\/NXI.0000000000001125","article-title":"Abnormal B-cell and tfh-cell profiles in patients with Parkinson disease: a cross-sectional study","volume":"9","author":"Li","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.parkreldis.2023.105890_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad060","article-title":"B lymphocyte responses in Parkinson's disease and their possible significance in disease progression","volume":"5","author":"Scott","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.parkreldis.2023.105890_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.parkreldis.2023.105890_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105890_bib10","doi-asserted-by":"crossref","first-page":"13485","DOI":"10.1073\/pnas.0605993103","article-title":"Dopamine targets cycling B cells independent of receptors\/transporter for oxidative attack: implications for non-Hodgkin\u2019s lymphoma","volume":"103","author":"Meredith","year":"2006","journal-title":"P Natl. Acad. Sci. Usa"},{"key":"10.1016\/j.parkreldis.2023.105890_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","article-title":"Reduced T helper and B lymphocytes in Parkinson's disease","volume":"252","author":"Stevens","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/07853890.2022.2031272","article-title":"Comparison of the deep immune profiling of B cell subsets between healthy adults and Sj\u00f6gren\u2019s syndrome","volume":"54","author":"Feng","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.parkreldis.2023.105890_bib13","series-title":"Systems and Synthetic Immunology","first-page":"125","article-title":"A chronological journey of breg subsets: implications in health and disease","author":"Dar","year":"2020"},{"key":"10.1016\/j.parkreldis.2023.105890_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/rheumatology\/kex455","article-title":"Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease","volume":"57","author":"Kubo","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.parkreldis.2023.105890_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-017-1231-2","article-title":"Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease","volume":"19","author":"Lin","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.parkreldis.2023.105890_bib16","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.167.4.2361","article-title":"Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus","volume":"167","author":"Arce","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1756285610371146","article-title":"Atacicept: targeting B cells in multiple sclerosis","volume":"3","author":"Hartung","year":"2010","journal-title":"Ther Adv. Neurol. Dis."},{"key":"10.1016\/j.parkreldis.2023.105890_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.13615","article-title":"Double\u2010negative (DN) B cells: an under\u2010recognized effector memory B cell subset in autoimmunity","volume":"205","author":"Li","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.parkreldis.2023.105890_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.5607\/en.2019.28.6.720","article-title":"B cell immunophenotyping and transcriptional profiles of memory B cells in patients with myasthenia gravis","volume":"28","author":"Min","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib21","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4049\/jimmunol.1801236","article-title":"Phenotypic and ig repertoire analyses indicate a common origin of IgD-CD27- double negative B cells in healthy individuals and multiple sclerosis patients","volume":"203","author":"Fraussen","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"\u00c1lvarez-Luqu\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2023.105890_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib24","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","article-title":"Interferon-\u03b3 signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells","volume":"11","author":"Panagiotakopoulou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.parkreldis.2023.105890_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.parkreldis.2023.105890_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08830185.2016.1276903","article-title":"Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases","volume":"36","author":"Samy","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.parkreldis.2023.105890_bib27","article-title":"Pathogenic role of a proliferation-inducing ligand (APRIL) in murine IgA nephropathy","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2023.105890_bib28","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3390\/ijms23084115","article-title":"CD40\u2013CD40L in neurological disease","volume":"23","author":"Ots","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105890_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40259-020-00443-w","article-title":"Monoclonal antibody-based therapies for myasthenia gravis","volume":"34","author":"Alabbad","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.parkreldis.2023.105890_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1155\/1998\/69628","article-title":"CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis","volume":"6","author":"Laman","year":"1998","journal-title":"Dev. Immunol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T02:27:25Z","timestamp":1716172045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"alternative-id":["S1353802023009690"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105890","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105890"}}